The challenges of introducing routine G6PD testing into radical cure: a workshop report-Reference-Cited by-同舟云学术

The challenges of introducing routine G6PD testing into radical cure: a workshop report

Published:2015-09-29 Issue:1 Volume:14 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Ley Benedikt,Luter Nick,Espino Fe Esperanza,Devine Angela,Kalnoky Michael,Lubell Yoel,Thriemer Kamala,Baird J. Kevin,Poirot Eugenie,Conan Nolwenn,Kheong Chong Chee,Dysoley Lek,Khan Wasif Ali,Dion-Berboso April G.,Bancone Germana,Hwang Jimee,Kumar Ritu,Price Ric N.,von Seidlein Lorenz,Domingo Gonzalo J.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/s12936-015-0896-8

Reference53 articles.

1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(6 Suppl):79–87.

2. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9:555–66. doi: 10.1016/S1473-3099(09)70177-X .

3. Carlton JM, Sina BJ, Adams JH. Why is Plasmodium vivax a neglected tropical disease? PLoS Neglect Trop Dis. 2011;5:e1160. doi: 10.1371/journal.pntd.0001160 .

4. Price RN. Improving the radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg. 2014;91:3–4. doi: 10.4269/ajtmh.14-0118 .

5. Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, et al. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother. 2010;54:792–8. doi: 10.1128/AAC.00354-09 .

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing test and treat options for vivax malaria: An options assessment toolkit (OAT) for Asia Pacific national malaria control programs;PLOS Global Public Health;2024-05-22

2. Electric pulse exposure reduces AAV8 dosage required to transduce HepG2 cells;PLOS ONE;2024-04-30

3. Optimizing test and treat options for Vivax malaria: an options assessment toolkit (OAT) for Asia Pacific National Malaria Control Programs;2024-02-08

4. Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review;Frontiers in Genetics;2023-06-14

5. The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review;Pharmacogenomics and Personalized Medicine;2023-05